Last update 19 Jun 2024
INA-03
Last update 19 Jun 2024
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms INA 03, INA03 |
Target |
Mechanism TfR1 antagonists(Transferrin receptor protein 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Structure
Molecular FormulaC39H67N5O7 |
InChIKeyDASWEROEPLKSEI-UIJRFTGLSA-N |
CAS Registry474645-27-7 |
Boost your research with our XDC technology data.
login
or
Related
1
Clinical Trials associated with INA-03A Phase I, First in Human, Open-label Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia
100 Clinical Results associated with INA-03
Login to view more data
100 Translational Medicine associated with INA-03
Login to view more data
100 Patents (Medical) associated with INA-03
Login to view more data
100 Deals associated with INA-03
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute lymphoblastic leukemia recurrent | Phase 1 | FR | 29 May 2020 | |
| Mixed phenotype acute leukemia | Phase 1 | FR | 29 May 2020 | |
| Refractory Acute Leukemia | Phase 1 | FR | 29 May 2020 | |
| Relapsing acute myeloid leukemia | Phase 1 | FR | 29 May 2020 | |
| Acute Biphenotypic Leukemia | Phase 1 | FR | 22 Jan 2020 | |
| Acute Myeloid Leukemia | Phase 1 | FR | 14 Jan 2020 | |
| Acute Lymphoblastic Leukemia | Phase 1 | FR | 12 Jan 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 27 | bwxtfhqfpb(qcupviiouo) = zdrbbgzzpv jwhhrpbmij (rurpsrrugy ) | - | 11 Dec 2023 | |||
Phase 1 | 22 | zkevwxrcre(mztifcwbbp) = tujxdrevmt mtyejgswls (oulqezipvh ) | - | 08 Jun 2023 | |||
NCT03957915 (ASCO2023) Manual  | Phase 1 | 22 | jzlkprulah(aolbsarqme) = spblezmybf bfhkmoojtv (iflarycosc ) View more | Positive | 26 May 2023 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free